2. 您的位置
3. 首页
4. 会议论文
5. New Drug Targets and Treatment Approaches to Target Drug-insensitive Cancer Stem Cells in Human Leuk

New Drug Targets and Treatment Approaches to Target Drug-insensitive Cancer Stem Cells in Human Leuk

来源 :2016第九届世界癌症大会 | 被引量 : 0次 | 上传用户：weiqiangting

【摘 要】

：

　　ABL tyrosine kinase inhibitor (TKI) therapies have had a major impact on treatment of chronic myeloid leukemia (CML) worldwide.However,TKI monotherapies are

【作 者】

：

Xiaoyan Jiang 

【机 构】

：

BCCancerResearchCentre&UniversityofBritishColombiaCanada

【出 处】

：

2016第九届世界癌症大会

【发表日期】

：

2016年5期

下载到本地 , 更方便阅读

下载此文 赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

　　ABL tyrosine kinase inhibitor (TKI) therapies have had a major impact on treatment of chronic myeloid leukemia (CML) worldwide.However,TKI monotherapies are not curative and initial and acquired TKI resistance,as well as relapse,remain challenges.

其他文献

个性化体格生长评价方法

会议

营养素对身高生长的影响

会议

骨龄对身高生长的影响

会议

A Revolutionary Strategy of Cancer Targeting Gene-viro-therapy, CTGVT

　　The oncolytic virus was recently become a very hot topic and OncoHSV-GM-CSF has been licensed to be marketed by FDA.We innovate the Cancer Targeting Gene-Vi

会议

身高的生理学基础

会议

儿童身高保健案例分析

会议

New World of Therapy for Malignant Lymphoma

　　Precision (or personalized) cancer therapy matches patients with therapies based upon specific biomarkers (mutations leading to neo-antigens;cell surface an

会议

GPC5,A Novel Epigenetically Silenced Tumor Suppressor, Inhibits Tumor Growth by Suppressing Wntβ-cat

　　Glypican-5 (GPC5) is a member of the heparin sulfate proteoglycans.In present study,we confirmed that GPC5 was downregulated in lung adenocarcinoma tissues

会议

身高保健门诊所需条件

会议

Is Safely Curing Late-stage or Terminal Cancer Possible

　　Current and traditional technologies and products can not cure late-stage and terminal cancer patients are due to 1) side-effects in damaging normal cell,ti

会议